Dewormer
Short description:
1.Fed once every 12 weeks, which provides long-lasting protection against flea ticks for about 1 season, breaking the parasite life cycle and preventing resurgence
2.Quickly repel flea ticks and block the spread of insect-borne diseases
3.Safe. Hydrolyzed protein formula, extremely hypoallergenic
4.Convenient.Unaffected by weather and bathing, suitable for all breeds of dogs
| Target | For dogs only |
| Validity Period | 24 months. |
| Assay Strength: | (1)112.5mg (2)250mg (3)500mg （4)1000mg (5)1400mg |
| Storage | Sealed storage below 30℃. |
|
Weight(kg) |
Specification |
Quantity |
|
≥2~≤4.5 |
112.5mg/tablet |
1 |
|
＞4.5~≤10 |
250mg/tablet |
1 |
|
＞10~≤20 |
500mg/tablet |
1 |
|
＞20~≤40 |
1000mg/tablet |
1 |
|
＞40~≤56 |
1400mg/tablet |
1 |
|
＞56 |
Choose the right combination of specifications. |
＞56 |
This product should not be used on puppies under 8 weeks old or dogs weighing less than 2kg.
Do not use in dogs allergic to this product.
The dosing interval of this product shall not be less than 8 week.
Do not eat, drink or smoke while administering the drug. Wash hands thoroughly with soap and water immediately after contact with this product.
Keep out of reach of children.
Please check whether the package is intact before use. If it is damaged, do not use it.
Unused veterinary drugs and packaging materials should be disposed of in accordance with local regulations.
Can be used for breeding dogs, pregnant and lactating female dogs.
Fluralaner has a high plasma protein binding rate and may compete with other drugs with a high protein binding rate, such as non-steroidal anti-inflammatory drugs, coumarin derivative warfarin, etc. In vitro plasma incubation tests, there was no evidence of competitive plasma protein binding between fluralanerandcarprofen and warfarin. The clinical trials did not find any interaction between fluralaner and the daily medication used in dogs.
Can be used for breeding dogs, pregnant and lactating female dogs.
Fluralaner has a high plasma protein binding rate and may compete with other drugs with a high protein binding rate, such as non-steroidal anti-inflammatory drugs, coumarin derivative warfarin, etc. In vitro plasma incubation tests, there was no evidence of competitive plasma protein binding between fluralanerandcarprofen and warfarin. The clinical trials did not find any interaction between fluralaner and the daily medication used in dogs.
